Sirius Therapeutics

Sirius Therapeutics (SHANGHAI) Co., Ltd. focuses on the research and development of oligonucleotide drugs, guided by unmet clinical needs and committed to enhancing human health through innovative nucleic acid therapeutics. The company aims to become a leading player in the oligonucleotide field. With an international strategy that leverages the strengths of both China and the United States, and with internationally leading core technology platforms and proprietary intellectual property barriers, Sirius Therapeutics has built a rich product pipeline with global competitiveness, broad coverage, and continuous expansion from preclinical to clinical stages.